
KNIMS - The Karolinska Neuroimmunology & Multiple Sclerosis Network
The Karolinska Neuroimmunology & Multiple Sclerosis (KNIMS) network is a collective of neurological clinical and preclinical research scientists working actively to:
(1) provide first-class medical care for individuals with neurological disorders
(2) to understand their underlying pathogenic mechanisms
(3) to develop diagnostic tools and therapeutic modalities for their improved diagnosis and treatment.

Our Vision
About us

Our Researchers
KNIMS researchers

News
KNIMS News
Highlights

Gonçalo Castelo-Branco awarded prestigious ERC Proof of Concept grant

The Karolinska Neuroimmunology & Multiple Sclerosis Network hosted Nobel Symposium 2025
On June 5, 2025, the Karolinska Neuroimmunology & Multiple Sclerosis Network (KNIMS) PIs hosted The Nobel Symposium - Multiple Sclerosis: from molecular mechanisms to disease-modifying treatments.

KNIMS receives the award “Excellence in Neuroscience Annual Reward”
KNIMS distinction was recognized by the “Excellence in Neuroscience Annual Reward (EINAR)” prize awarded during the Clinical Neuroscience Department Day on May 26, 2025.